Hormone Replacement Therapy Market

Published Jul 24, 2025

Length 151 Pages

SKU # CMI20302796

Description

The global hormone replacement therapy market is estimated to be valued at USD 15.78 Bn in 2025 and is expected to exhibit a CAGR of 6.0% during the forecast period (2025-2032). The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study

This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hormone replacement therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Market Segmentation

Therapy Type Insights (Revenue, USD Bn, 2020 - 2032)
Estrogen Replacement Therapy
Human Growth Hormone (HGH) Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Others
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
Oral
Parenteral
Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Novartis AG
Abbott
Mylan NV
Merck KgaA
Bayer AG
Pfizer Inc.
Novo Nordisk A/S
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Amgen, Inc.
Eli Lilly and Company
Halozyme Therapeutics, Inc.
AbbVie, Inc.
Noven Pharmaceuticals, Inc.
I-MAB Biopharma Co., Ltd.
Myovant Sciences

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Therapy Type; Market Snapshot, By Route of Administration; Market Snapshot, By Application; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunities; Impact Analysis; Market Trends; Key Developments; Regulatory Scenario; Manufacturer Revenue; Adoption of Non-invasive Sensor Technologies; Acquisitions and Partnerships Scenario; Product Launches/Approvals; Funding and Investments; PEST Analysis; Porter’s Analysis
4. Global Hormone Replacement Therapy Market, By Therapy Type, 2020 – 2032, (USD Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Estrogen Replacement Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Human Growth Hormone (HGH) Replacement Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Thyroid Replacement Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Testosterone Replacement Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion)
5. Global Hormone Replacement Therapy Market, By Route of Administration, 2020 – 2032, (USD Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Oral; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Parenteral; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion)
6. Global Hormone Replacement Therapy Market, By Application, 2020 – 2032, (USD Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Hypothyroidism; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Male Hypogonadism; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Growth Hormone Deficiency; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion)
7. Global Hormone Replacement Therapy Market, By Distribution Channel, 2020 – 2032, (USD Billion): Overview; Market Share Analysis, 2025 and 2032 (%); Y-o-Y Growth Analysis, 2021 – 2032; Segment Trends; Hospital Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Retail Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion); Online Pharmacies; Overview; Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (USD Billion)
8. Global Hormone Replacement Therapy Market, By Region, 2020 – 2032, (USD Billion): Introduction; Market Share Analysis, By Region, 2025 and 2032 (%); Y-o-Y Growth Analysis, For Region, 2021–2032; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Billion); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Billion); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Billion); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Billion); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (USD Billion); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Billion); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (USD Billion); North Africa; Central Africa; South Africa
9. Competitive Landscape: Company Profiles; Novartis AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Abbott; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Mylan NV; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Merck KgaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Bayer AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Pfizer Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Novo Nordisk A/S; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; QuatRx Pharmaceuticals; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Teva Pharmaceutical Industries Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Amgen, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Eli Lilly and Company; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Halozyme Therapeutics, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; AbbVie, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Noven Pharmaceuticals, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; I-MAB Biopharma Co., Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Myovant Sciences; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
10. Analyst View: Wheel of Fortune; Analyst View; Coherent Opportunity Map
11. References and Research Methodology: References; Research Methodology; About us and Sales Contact; *Browse 32 market data tables and 28 figures on Hormone Replacement Therapy Market” - Global forecast to 2032

Pricing

Currency Rates

Single User Email from Publisher $4,500
Site License Fulfilled by Publisher $7,000
Global Site License Email from Publisher $10,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now